Global Wheat Stocks Dwindle for Fifth Straight Year, Intensifying Export Competition
Hedder1 minute ago
Global wheat stocks are projected to decline for the fifth consecutive year, reaching their lowest levels since 2015/16, as major exporting countries grapple with smaller harvests and robust demand, according to a report published by the USDA's Foreign Agricultural Service (FAS).
Cotton Prices Soften as Supply Concerns Ease and Chinese Demand Uncertain
Hedder4 minutes ago
Cotton prices have retreated in recent weeks, reflecting an easing of concerns about exportable supplies and uncertainty regarding Chinese import demand in the upcoming 2024/25 marketing year, according to a report by Cotton Incorporated.
Stock Index Futures Tread Water Ahead of Key U.S. PPI Data and Powell Remarks
Barchart27 minutes ago
June S&P 500 E-Mini futures (ESM24) are up +0.02%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.03% this morning as investors geared up for crucial U.S. producer inflation data while also awaiting comments from Federal Reserve Chair Jerome Powell.
ETHBTC Pair Is Finishing A Flat Correction
WavetradersTue May 14, 1:13AM CDT
ETHBTC Pair Is Finishing A Flat Correction, as we see a corrective price action from technical perspective and by Elliott wave theory.
AgDay Markets Now: Brian Grete Says Wheat Continues to Lead Grains Higher Triggering Fund Short Covering
AgWebMon May 13, 9:08PM CDT
National Watermelon Report
USDAMon May 13, 7:34PM CDT
Click to view report fvdtvmelon.pdf in PDF format
Possible tornado leaves trail of damage across southwest Louisiana town
Fox WeatherMon May 13, 7:22PM CDT
LAKE CHARLES, La. – A possible tornado tore a path across the Lake Charles area in southwest Louisiana on Monday.According to storm reports from the National Weather Service, damage was first reported by emergency officials near Sulphur, which is to the west of Lake Charles. That is where reports of...
1 'Strong Buy' Dividend Stock to Buy and Hold
BarchartMon May 13, 6:30PM CDT
Discover why Eli Lilly is considered a 'strong buy' as it capitalizes on the growing demand for diabetes and obesity treatments, backed by its robust financial performance and promising future prospects.